GOUT INDUCED BY L-DOPA AND DECARBOXYLASE INHIBITORS

被引：9

作者：

CALNE, DB

FERMAGLICH, J

机构：

[1] NINCDS,DEPT HEW,BETHESDA,MD 20014

[2] GEORGETOWN UNIV HOSP,DEPT NEUROL,WASHINGTON,DC 20007

来源：

POSTGRADUATE MEDICAL JOURNAL | 1976年 / 52卷 / 606期

关键词：

D O I：

10.1136/pgmj.52.606.232

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：232 / 233

页数：2

共 50 条

[1] MODIFICATION OF CARDIOVASCULAR EFFECTS OF L-DOPA BY DECARBOXYLASE INHIBITORS
WATANABE, AM
PARKS, LC
KOPIN, IJ
JOURNAL OF CLINICAL INVESTIGATION, 1971, 50 (06): : 1322 - &
[2] MONITORING OF BLOOD DOPA LEVELS DURING ADMINISTRATION OF L-DOPA AND INHIBITORS OF DOPA DECARBOXYLASE
ROYER, RJ
KISSEL, P
HUMBERT, F
NETTER, P
ROYERMORROT, MJ
JOURNAL DE PHARMACOLOGIE, 1975, 6 (03) : 365 - 366
[3] DECARBOXYLASE INHIBITORS ASSOCIATED TO L-DOPA IN TREATMENT OF PARKINSONS DISEASE
RONDOT, P
REVUE DU PRATICIEN, 1974, 24 (15): : 1211 - &
[4] TRANSITION-STATE ANALOGS AS INHIBITORS OF L-DOPA DECARBOXYLASE
BRINKWORTH, RI
ILES, MM
ISKANDER, MN
ANDREWS, PR
INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1988, 20 (11): : 1273 - 1279
[5] L-DOPA INFUSION EXPERIMENTS IN COMBINATION WITH THE L-DOPA-DECARBOXYLASE INHIBITORS BENSERAZIDE AND CARBIDOPA - L-DOPA METABOLISM AND NEUROENDOCRINOLOGICAL EFFECTS
KAPFHAMMER, HP
KUSS, HJ
EBEN, E
RUTHER, E
PHARMACOPSYCHIATRY, 1985, 18 (01) : 143 - 144
[6] RISKS OF PARKINSONISM TREATMENT WITH L-DOPA AND L-DOPA DECARBOXYLASE INHIBITOR
JORG, J
MEDIZINISCHE WELT, 1979, 30 (46): : 1740 - 1742
[7] EFFECT OF A TREATMENT WITH L-DOPA OR L-DOPA AND DOPA-DECARBOXYLASE INHIBITORS ON BRAIN CONCENTRATION OF S-ADENOSYL-L-METHIONINE IN MICE
STRAMENTINOLI, G
CATTO, E
AGNOLI, A
PHARMACOLOGY, 1981, 22 (01) : 85 - 86
[8] ACTIVITY OF L-DOPA DECARBOXYLASE ON METAL L-DOPA CHELATE - INVITRO STUDIES
RAJAN, KS
WIEHLE, RD
ROBINSON, M
DAVIS, JM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (APR): : 86 - 86
[9] TREATMENT OF IDIOPATHIC PARKINSONISM WITH L-DOPA IN THE ABSENCE AND PRESENCE OF DECARBOXYLASE INHIBITORS - EFFECTS ON PLASMA-LEVELS OF L-DOPA, DOPA DECARBOXYLASE, CATECHOLAMINES AND 3-O-METHYL-DOPA
BOOMSMA, F
MEERWALDT, JD
INTVELD, AJM
HOVESTADT, A
SCHALEKAMP, MADH
JOURNAL OF NEUROLOGY, 1989, 236 (04) : 223 - 230
[10] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND AN ASSOCIATION L-DOPA PLUS A DOPA DECARBOXYLASE INHIBITOR
FAZIO, C
BARBA, C
CASACCHIA, M
AGNOLI, A
RUGGIERI, S
VOLANTE, F
REITANO, M
ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 347 - +

← 1 2 3 4 5 →